Literature DB >> 21301436

The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.

Bonnie W McLeod1, Mark L Hayman, Angela L Purcell, Joshua S Marcus, Erich Veitenheimer.   

Abstract

Strategies are needed for drafting miRNA patent applications, in light of the existing patent landscape and genomic patent strategies of the past decades.

Mesh：

Substances：

Year:  2011        PMID： 21301436     DOI： 10.1038/nbt.1765

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


  22 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  Functions of microRNAs in Drosophila development.

Authors:  Christopher I Jones; Sarah F Newbury
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

3.  ESTs stumble at the utility threshold.

Authors:  Paula K Davis; James J Kelley; Steven P Caltrider; Stephen J Heinig
Journal:  Nat Biotechnol       Date:  2005-10       Impact factor: 54.908

Review 4.  MicroRNAs and viral infection.

Authors:  Christopher S Sullivan; Don Ganem
Journal:  Mol Cell       Date:  2005-10-07       Impact factor: 17.970

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 7.  MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease.

Authors:  W H Davin Townley-Tilson; Thomas E Callis; DaZhi Wang
Journal:  Int J Biochem Cell Biol       Date:  2009-03-14       Impact factor: 5.085

Review 8.  MicroRNAs in cardiac remodeling and disease.

Authors:  Zhan-Peng Huang; Ronald L Neppl; Da-Zhi Wang
Journal:  J Cardiovasc Transl Res       Date:  2010-02-17       Impact factor: 4.132

Review 9.  microRNA, cell cycle, and human breast cancer.

Authors:  Zuoren Yu; Renato Baserga; Lide Chen; Chenguang Wang; Michael P Lisanti; Richard G Pestell
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307

10.  Accurate microRNA target prediction correlates with protein repression levels.

Authors:  Manolis Maragkakis; Panagiotis Alexiou; Giorgio L Papadopoulos; Martin Reczko; Theodore Dalamagas; George Giannopoulos; George Goumas; Evangelos Koukis; Kornilios Kourtis; Victor A Simossis; Praveen Sethupathy; Thanasis Vergoulis; Nectarios Koziris; Timos Sellis; Panagiotis Tsanakas; Artemis G Hatzigeorgiou
Journal:  BMC Bioinformatics       Date:  2009-09-18       Impact factor: 3.169
View more
  4 in total

1.  The "real world" barriers and solutions to Candida vaccine patent prosecutions: an analysis of U.S. Patent and Trademark Office actions on related applications.

Authors:  Shyh-Jen Wang
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Is silence still golden? Mapping the RNAi patent landscape.

Authors:  Per Lundin
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

Review 3.  Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Garima Sharma; C George Priya Doss; Sang-Soo Lee
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-12       Impact factor: 8.886

Review 4.  Development of MicroRNA Therapeutics for Hepatocellular Carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  Diagnostics (Basel)       Date:  2013-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.